3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
8
Myelodysplastic Syndromes
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Hodgkin Disease
5
Myeloproliferative Disorders
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Biphenotypic, Acute
3
Burkitt Lymphoma
3
Recurrence
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Chronic
2
Sarcoma
1
Neoplasms
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphadenopathy
1
Leukemia, Prolymphocytic
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Large Granular Lymphocytic
1
Leukemia
1
Hematologic Neoplasms
1
Interventions
Imatinib Mesylate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Congenital Bone Marrow Failure Syndromes
×
Granulocyte Colony-Stimulating Factor
×
30 days
×
Clear all
No trials found.